Case Review of Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: TAI, Ching-Ling (Chiay country, China Taiwan)
- Co-author(s): Lin, P.T. (Chiayi branch of CGMH, Chiayi, China Taiwan)
Platinum antineoplastic agents, cispltin, carboplatin and oxaliplatin, are one of the first line chemotherapy agents of lots of cancer. Hypersensitivity reactions will increase the burden of patients and caregivers and the incidence of adverse drug reactions (ADRs) increases as extensive use.
The data was claimed from the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.